"... the suggestion that success by any one of at least seven companies worldwide investigating oncolytic viruses could re-rate Viralytics as it would validate the field."
VLA now has to depend on others success to gain any kind appreciaton...and that's a good thing?
vlao options 3.3c ; vla shares 5.6c ???, page-17
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)